Literature DB >> 20412438

Association of A31P and A74T polymorphisms in the myosin binding protein C3 gene and hypertrophic cardiomyopathy in Maine Coon and other breed cats.

G Wess1, C Schinner, K Weber, H Küchenhoff, K Hartmann.   

Abstract

BACKGROUND: Hypertrophic cardiomyopathy (HCM) is an inherited autosomal dominant trait in cats. The A31P single nucleotide polymorphism (SNP) in the myosin binding protein C 3 gene is thought to be the causative mutation in Maine Coon cats. Additionally, the A74T SNP is offered as a genetic test for HCM.
OBJECTIVES: To evaluate the genetic association between the above-mentioned SNPs and phenotypes. ANIMALS: Eighty-three Maine Coon cats and 68 cats of other breeds.
METHODS: The study was performed prospectively. Cats were phenotyped as healthy or HCM with echocardiography. Taqman genotyping assays were used for genotyping; results were confirmed by sequencing analysis.
RESULTS: A31P was found in 18/83 (22%) Maine Coon cats. Fifteen of 18 Maine Coons (83%) with the A31P mutation were healthy on echocardiographic examination (mean age 65 months). A74T was present in 28/79 (35%) of Maine Coons and in 42/68 (62%) of other cat breeds. Twenty-two of 28 (79%) of Maine Coons and 21/42 (62%) of other breed cats with the A74T mutation were healthy at a mean age of 72 months and 91 months, respectively. Of 12 Maine Coons with HCM, 9 (75%) were genotype-negative for A31P and 6 (50%) for A74T. Allele frequencies did not differ significantly (P= .47) between phenotype groups. None of the evaluated genetic tests was able to provide useful predictive information of disease outcome. CONCLUSIONS AND CLINICAL IMPORTANCE: The value of currently available genetic tests is low in the cats of this study. The mutations analyzed appear to have a low penetrance, and even homozygote cats can remain healthy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20412438     DOI: 10.1111/j.1939-1676.2010.0514.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  17 in total

Review 1.  The genetic basis of hypertrophic cardiomyopathy in cats and humans.

Authors:  Mark D Kittleson; Kathryn M Meurs; Samantha P Harris
Journal:  J Vet Cardiol       Date:  2015-12       Impact factor: 1.701

2.  Assessment of regional left ventricular systolic function by strain imaging echocardiography in phenotypically normal and abnormal Maine coon cats tested for the A31P mutation in the MYBPC3 gene.

Authors:  Arine Pellegrino; Alexandre G T Daniel; Guilherme G Pereira; Paula H Itikawa; Maria Helena M A Larsson
Journal:  Can J Vet Res       Date:  2017-04       Impact factor: 1.310

Review 3.  Feline genetics: clinical applications and genetic testing.

Authors:  Leslie A Lyons
Journal:  Top Companion Anim Med       Date:  2010-11

Review 4.  Genetic testing in domestic cats.

Authors:  Leslie A Lyons
Journal:  Mol Cell Probes       Date:  2012-04-21       Impact factor: 2.365

5.  Serum microRNA profiles in cats with hypertrophic cardiomyopathy.

Authors:  K Weber; N Rostert; S Bauersachs; G Wess
Journal:  Mol Cell Biochem       Date:  2015-01-09       Impact factor: 3.396

6.  Myosin-binding protein C DNA variants in domestic cats (A31P, A74T, R820W) and their association with hypertrophic cardiomyopathy.

Authors:  M Longeri; P Ferrari; P Knafelz; A Mezzelani; A Marabotti; L Milanesi; G Pertica; M Polli; P G Brambilla; M Kittleson; L A Lyons; F Porciello
Journal:  J Vet Intern Med       Date:  2013-01-17       Impact factor: 3.333

Review 7.  Inherited cardiomyopathies in veterinary medicine.

Authors:  Joshua A Stern; Yu Ueda
Journal:  Pflugers Arch       Date:  2018-10-03       Impact factor: 3.657

8.  Hypertrophic cardiomyopathy in young Maine Coon cats caused by the p.A31P cMyBP-C mutation--the clinical significance of having the mutation.

Authors:  Mia T N Godiksen; Sara Granstrøm; Jørgen Koch; Michael Christiansen
Journal:  Acta Vet Scand       Date:  2011-02-09       Impact factor: 1.695

9.  International collaborative study to assess cardiovascular risk and evaluate long-term health in cats with preclinical hypertrophic cardiomyopathy and apparently healthy cats: The REVEAL Study.

Authors:  Philip R Fox; Bruce W Keene; Kenneth Lamb; Karsten A Schober; Valerie Chetboul; Virginia Luis Fuentes; Gerhard Wess; Jessie Rose Payne; Daniel F Hogan; Alison Motsinger-Reif; Jens Häggström; Emilie Trehiou-Sechi; Deborah M Fine-Ferreira; Reid K Nakamura; Pamela M Lee; Manreet K Singh; Wendy A Ware; Jonathan A Abbott; Geoffrey Culshaw; Sabine Riesen; Michele Borgarelli; Michael B Lesser; Nicole Van Israël; Etienne Côté; John E Rush; Barret Bulmer; Roberto A Santilli; Andrea C Vollmar; Maribeth J Bossbaly; Nadine Quick; Claudio Bussadori; Janice M Bright; Amara H Estrada; Dan G Ohad; Maria Josefa Fernández-Del Palacio; Jenifer Lunney Brayley; Denise S Schwartz; Christina M Bové; Sonya G Gordon; Seung Woo Jung; Paola Brambilla; N Sydney Moïse; Christopher D Stauthammer; Rebecca L Stepien; Cecilia Quintavalla; Christophe Amberger; Ferenc Manczur; Yong-Wei Hung; Remo Lobetti; Marie De Swarte; Alice Tamborini; Carmel T Mooney; Mark A Oyama; Andrey Komolov; Yoko Fujii; Romain Pariaut; Masami Uechi; Victoria Yukie Tachika Ohara
Journal:  J Vet Intern Med       Date:  2018-04-16       Impact factor: 3.333

Review 10.  Genomic Insights into Cardiomyopathies: A Comparative Cross-Species Review.

Authors:  Siobhan Simpson; Paul Rutland; Catrin Sian Rutland
Journal:  Vet Sci       Date:  2017-03-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.